CLONIDINE HYDROCHLORIDE
- Product NDC
- 10135-709
- 11-digit product format
- 101350709
- Labeler code
- 10135
- Product ID
- 10135-709_ce8104b1-ca95-1808-e053-2995a90a7126
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Clonidine hydrochloride
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Marlex Pharmaceuticals Inc
- Application
- ANDA202297
- Marketing category
- ANDA
- Marketing start
- 2020-10-01
- Marketing end
- 0000-00-00
- Substance
- CLONIDINE HYDROCHLORIDE
- Active strength
- 0 mg/1
- Pharmacologic classes
- Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 10135-709-01 | CLONIDINE HYDROCHLORIDE | 100 in 1 BOTTLE | TABLET | 100 | | 3 |
| 10135-709-05 | CLONIDINE HYDROCHLORIDE | 500 in 1 BOTTLE | TABLET | 500 | | 3 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 10135-709 | CLONIDINE HYDROCHLORIDE TABLET [MARLEX PHARMACEUTICALS INC] | 3 | Legacy NDC, 2 package rows | 20211018_57ad4805-294a-4b3e-94af-ce3869635d63.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 10135-709-01 | 10135070901 | 100 TABLET in 1 BOTTLE (10135-709-01) | 100 tablet | 2020-10-01 | 0000-00-00 | No | No | Current |
| 10135-709-05 | 10135070905 | 500 TABLET in 1 BOTTLE (10135-709-05) | 500 tablet | 2020-10-01 | 0000-00-00 | No | No | Current |